FDA Authorizes Use of New Eli Lilly Covid-19 Antibody Treatment

Norge Nyheter Nyheter

FDA Authorizes Use of New Eli Lilly Covid-19 Antibody Treatment
Norge Siste Nytt,Norge Overskrifter
  • 📰 WSJ
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 63%

The FDA authorized the use of a new Covid-19 antibody drug from Eli Lilly that retains effectiveness against the Omicron variant, filling a void after authorities stopped distributing some older antibody drugs that lost effectiveness against the strain

U.S. drug regulators authorized the use of a new Covid-19 antibody drug from Eli Lilly & Co. that retains effectiveness against the Omicron variant of the virus, filling a void after authorities stopped distributing some older antibody drugs that lost effectiveness against the strain.

The Food and Drug Administration on Friday cleared the drug, bebtelovimab, for the treatment of mild to moderate Covid-19 in nonhospitalized individuals 12 and older who are at high risk of getting severely sick. The drug is intended for people who can’t get access to alternative Covid-19 treatments, or for whom those treatments aren’t appropriate.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

WSJ /  🏆 98. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

U.S. to buy 600,000 doses of Eli Lilly COVID treatmentU.S. to buy 600,000 doses of Eli Lilly COVID treatmentThe U.S. is set to buy 600,000 doses of Eli Lilly’s developmental drug bebtelovimab, an antibody treatment that’s been found to neutralize COVID variants including Omicron.
Les mer »

FDA Committee Votes Against Eli Lilly Cancer Treatment Over Concerns Trials Conducted Only in ChinaFDA Committee Votes Against Eli Lilly Cancer Treatment Over Concerns Trials Conducted Only in ChinaFDA committee members said the trial population of mostly Asian men did not represent the diversity of U.S. patients.
Les mer »

In reversal, FDA puts brakes on COVID shots for kids under 5In reversal, FDA puts brakes on COVID shots for kids under 5The shots for kids may not be reviewed until April.
Les mer »

Pfizer pulls FDA request for COVID-19 vaccine for kids under 5Pfizer pulls FDA request for COVID-19 vaccine for kids under 5The company said it believes three doses “may provide a higher level of protection in this age group.”
Les mer »

US preps 10 million doses of COVID-19 vaccine for kids under 5, pending FDA authorizationUS preps 10 million doses of COVID-19 vaccine for kids under 5, pending FDA authorizationCOVID-19 vaccines for kids under 5 have not yet been authorized, but the rollout plan is already in the works.
Les mer »

Young kids’ COVID vaccines create approval dilemma for FDAYoung kids’ COVID vaccines create approval dilemma for FDATwo doses of Pfizer's vaccine showed mixed results in trials, but the agency is considering approving it anyways in anticipation that a future third shot will provide children with strong immunity.
Les mer »



Render Time: 2025-03-19 08:17:23